Intraventricular nicardipine for aneurysmal subarachnoid hemorrhage related vasospasm: Assessment of 90 days outcome

Neurocritical Care

Volumn 16, Issue 3, 2012, Pages 368-375

  Lu, Na ^a   Jackson, Daniel ^a   Luke, Sothear ^a   Festic, Emir ^a   Hanel, Ricardo A ^a   Freeman, William David ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aneurysmal subarachnoid hemorrhage; Intraventricular; Nicardipine; Vasospasm

Indexed keywords

NICARDIPINE; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN VASOSPASM; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER; FOLLOW UP; INTENSIVE CARE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METHODOLOGY; TIME; TREATMENT OUTCOME;

ADULT; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTENSIVE CARE; MALE; MIDDLE AGED; NICARDIPINE; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84873045357     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9659-8     Document Type: Article

References (24)

1. Edlow JA, Malek AM, Ogilvy CS. Aneurysmal subarachnoid hemorrhage: update for emergency physicians. J Emerg Med. 2008;34:237-51.
2. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:2315-28.
3. Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009; 40:994-1025.
4. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery. 2001;48: 249-61. discussion 61-62.
5. Goodson K, Lapointe M, Monroe T, Chalela JA. Intraventricular nicardipine for refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2008;8:247-52.
6. Webb A, Kolenda J, Martin K, Wright W, Samuels O. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;12:159-64.
7. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128-33.
8. Amenta F, Lanari A, Mignini F, Silvestrelli G, Traini E, Tomassoni D. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies. J Neurol Sci. 2009;283:219-23.
9. Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study. J Neurosurg. 1993;78:537-47.
10. Barth M, Thome C, Schmiedek P, Weiss C, Kasuya H, Vajkoczy P. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants. J Neurosurg. 2009;110:955-60.
11. Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J. 2009;102:150-3.
12. Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit care. 2011;15:400-4.
13. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002;33:1011-5.
14. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke. 2007;38:330-6.
15. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
16. CONSCIOUS-3 Clinical Trial. Internet Stroke Center.org. 2011. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=1013. Accessed Aug, 2011.
17. Washington CW, Zipfel GJ. Detection and monitoring of vasospasm and delayed cerebral ischemia: a review and assessment of the literature. Neurocrit care. 2011;15:312-7.
18. Cerebrovascular ultrasound in stroke prevention and treatment. Elmsford: Blackwell Publishing; 2004. p 161-169.
19. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101:1-7.
20. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;10:157-65.
21. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-507.
22. Tseng MY, Hutchinson PJ, Kirkpatrick PJ. Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study. Br J Neurosurg. 2008;22:257-68.
23. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006;59:775-9. discussion 9-80.
24. Kramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey. Crit Care. 2011;15:R30.